Sodium Picosulfate and Magnesium Oxide and Anhydrous Citric Acid
Brand names: Sodium Picosulfate, Magnesium Oxide And Anhydrous Citric Acid · Active ingredient: Sodium Picosulfate, Magnesium Oxide, Anhydrous Citric Acid
In short: Sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older.
What is Sodium Picosulfate and Magnesium Oxide and Anhydrous Citric Acid used for?
Sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older.
Sodium Picosulfate and Magnesium Oxide and Anhydrous Citric Acid dosage
• Correct fluid and electrolyte abnormalities before administration of sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution
.
• Two doses (one packet per dose) of sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution are required for a complete preparation for colonoscopy either as a Split-Dose (preferred) or Day-Before dosing regimen.
• The preferred method is the “Split-Dose” method and consists of two separate doses: the first dose during the evening before the colonoscopy and the second dose the next day, the morning of the day of the colonoscopy
.
• The alternative method is the “Day Before” method and consists of two separate doses: the first dose during the afternoon or early evening before the colonoscopy and the second dose 6 hours later during the evening before the colonoscopy
.
• Each packet of sodium picosulfate, magnesium oxide and anhydrous citric acid must be dissolved in 5 ounces of cold water prior to ingestion and administered according to the dosing regimen. Direct ingestion of the undissolved powder may increase the risk of nausea, vomiting, dehydration and electrolyte disturbances
.
• Additional fluids must be consumed after every dose of sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution in both dosing regimens
.
• Consume only clear fluids (no solid food) from the start of sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution treatment until after the colonoscopy.
• Do not eat solid food or dairy and do not drink anything colored red or purple.
• Do not drink alcohol.
• Do not take other laxatives while taking sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution.
• Do not take oral medications within one hour before or after starting sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution.
• If taking tetracycline or fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, or penicillamine, take these medications at least 2 hours before and not less than 6 hours after administration of sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution
.
• Stop consumption of all fluids at least 2 hours before the colonoscopy.
1. Reconstitute the sodium picosulfate, magnesium oxide and anhydrous citric acid powder immediately before each administration. Do not prepare the solution in advance.
2. Fill the supplied dosing cup with cold water up to the lower (5-ounce) line on the cup and pour in the contents of one packet of sodium picosulfate, magnesium oxide and anhydrous citric acid powder.
3. Stir for 2 to 3 minutes. The reconstituted sodium picosulfate, magnesium oxide and anhydrous citric acid solution may become slightly warm as the powder dissolves. …
How to take Sodium Picosulfate and Magnesium Oxide and Anhydrous Citric Acid — instructions & advice from the label
Advise the patient to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).
Instruct patients:
• Each packet must be dissolved in 5 ounces of cold water and administered according to the dosing regimen. Direct ingestion of the undissolved powder may increase the risk of nausea, vomiting, dehydration, and electrolyte disturbances
.
• Two doses (one packet per dose) of sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution are required for a complete preparation for colonoscopy either as a Split-Dose (preferred) or Day-Before dosing regimen.
• Not to take other laxatives while they are taking sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution.
• Do not eat solid food or dairy and do not drink anything colored red or purple.
• Do not drink alcohol.
• Do not take oral medications within one hour of starting sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution. …
Warnings & precautions
Do not take this medicine if: Sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution is contraindicated in the following conditions:
• Patients with severe renal impairment (creatinine clearance less than 30 mL/minute) which may result in accumulation of magnesium
• Gastrointestinal obstruction or ileus
• Bowel perforation
• Toxic colitis or toxic megacolon
• Gastric retention
• Hypersensitivity to any of the ingredients in sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution
Advise patients to hydrate adequately before, during, and after the use of sodium picosulfate, magnesium oxide and anhydrous citric acid. Use caution in patients with congestive heart failure when replacing fluids. If a patient develops significant vomiting or signs of dehydration including signs of orthostatic hypotension after taking sodium picosulfate, magnesium oxide and anhydrous citric acid, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN) and treat accordingly. Approximately 20% of adult patients in both arms (sodium picosulfate, magnesium oxide and anhydrous citric acid, 2L of PEG + E plus two x 5 mg bisacodyl tablets) of clinical trials of sodium picosulfate, magnesium oxide and anhydrous citric acid had orthostatic changes (changes in blood pressure and/or heart rate) on the day of colonoscopy. In adult clinical trials orthostatic changes were documented up to seven days post colonoscopy. In a single study of patients 9 to 16 years of age, approximately 20% of patients in sodium picosulfate, magnesium oxide and anhydrous citric acid arms had orthostatic changes (changes in blood pressure and/or heart rate) compared with approximately 7% of those who received the comparator (PEG)
.
These changes occurred up to five days post colonoscopy. …
Sodium Picosulfate and Magnesium Oxide and Anhydrous Citric Acid side effects
The following serious or otherwise important adverse reactions for bowel preparations are described elsewhere in the labeling:
• Serious Fluid and Electrolyte Abnormalities
• Cardiac Arrhythmias
• Seizures
• Use in Patients with Renal Impairment
• Colonic Mucosal Ulceration, Ischemic Colitis and Ulcerative Colitis
• Use in Patients with Significant Gastrointestinal Disease
• Aspiration
• Risk of Vomiting and Other Gastrointestinal Complications with Ingestion of Undissolved Powder
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in clinical trials of another drug and may not reflect the rates observed in practice.
In randomized, multicenter, controlled clinical trials, nausea, headache, and vomiting were the most common adverse reactions (>1%) following sodium picosulfate, magnesium oxide and anhydrous citric acid administration. The patients were not blinded to the study drug. …
Drug interactions
Use caution when prescribing sodium picosulfate, magnesium oxide and anhydrous citric acid for patients with conditions and/or who are taking other drugs that increase the risk for fluid and electrolyte disturbances or may increase the risk of renal impairment, seizures, arrhythmias, or QT prolongation in the setting of fluid and electrolyte abnormalities
.
Sodium picosulfate, magnesium oxide and anhydrous citric acid can reduce the absorption of other co-administered drugs
:
• Administer oral medications at least one hour before of the start of administration of sodium picosulfate, magnesium oxide and anhydrous citric acid.
• Administer tetracycline and fluoroquinolone antibiotics
,
iron, digoxin, chlorpromazine, and penicillamine at least 2 hours before and not less than 6 hours after administration of sodium picosulfate, magnesium oxide and anhydrous citric acid.
Prior or concomitant use of antibiotics with sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution may reduce efficacy of sodium picosulfate, magnesium oxide and anhydrous citric acid as conversion of sodium picosulfate to its active metabolite BHPM is mediated by colonic bacteria.
About this medicine
Sodium picosulfate, magnesium oxide and anhydrous citric acid for oral solution is available in orange flavor, and is provided in two packets. The contents of each is to be dissolved in 5 ounces of cold water and consumed.
Each packet for orange flavor contains 10 mg sodium picosulfate, USP, 3.5 g magnesium oxide, USP and 12 g anhydrous citric acid, USP. The product also contains the following inactive ingredients: glyceryl behenate, orange flavor (contains dl-alpha-Tocopherol and Maize maltodextrin), potassium bicarbonate and saccharin sodium. The following is a description of the three active ingredients:
Sodium picosulfate is a stimulant laxative.
Sodium Picosulfate
• Chemical name: 4,4’-(2-Pyridylmethylene) diphenyl bis (hydrogen sulfate) disodium salt, monohydrate
• Chemical formula: C
18H
13NNa
2O
8S
2.H
2O
• Molecular weight: 499.4
• Structural formula:
• Sodium Picosulfate
Magnesium citrate, which is formed in solution by the combination of magnesium oxide and anhydrous citric acid, is an osmotic laxative. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID b759dc12-2dc1-4ef4-a375-1a61630d54d6. Read the full official label on DailyMed.